Possible functional regression of insulinoma with prolonged octreotide

Postgraduate Medical Journal

Volumn 78, Issue 924, 2002, Pages 623-624

  Craig, C E H ^a   Gallen, Ian W ^a  

^a WYCOMBE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; INSULIN; OCTREOTIDE; SOMATOSTATIN DERIVATIVE;

AGED; ARTICLE; CASE REPORT; CELIAC ANGIOGRAPHY; FEMALE; HUMAN; HYPOGLYCEMIC COMA; INSULIN BLOOD LEVEL; INSULINOMA; LAPAROTOMY; PANCREAS BLOOD FLOW; REMISSION;

AGED; ANTINEOPLASTIC AGENTS, HORMONAL; C-REACTIVE PROTEIN; CASE REPORT; DIABETIC COMA; FEMALE; HUMAN; HYPOGLYCEMIA; INSULIN; INSULINOMA; OCTREOTIDE; PANCREATIC NEOPLASMS;

EID: 0036809513     PISSN: 00325473     EISSN: None     Source Type: Journal    
DOI: 10.1136/pmj.78.924.623     Document Type: Article

References (10)

1. Battershill PE, Clissold SP. Octretide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in conditions associated with excessive peptide secretion. Drugs 1989;38:658-702.
2. Wass JAH, Williams J, Charlesworth M, et al. Bromocriptine in management of large pituitary tumours. BMJ 1982;284:1908-11.
3. Whipple AO, Frantz VK. Adenoma of islet cells with hyperinsulinism. Ann Surg 1935;101:1299-335.
4. Arem R, Garber AJ, Field JB. Sulfonamide-induced hypoglycaemia in chronic renal failure. Arch Intern Med 1983;143:827-9.
5. Virally ML, Timist J, Chanson PH, et al. Insulin autoimmune syndrome: A rare cause of hypoglycaemia not to be overlooked. Diabetes Metab 1999;25:429-31.
6. Von Eyben FE, Grodum E, Gjessing HJ, et al. Metabolic remission with octreotide in patients with insulinoma. J Intern Med 1994;235:245-8.
7. Vershoor L, Uitterlinden P, Lamberts SWJ, et al. On the use of a new somatostatin analogue in the treatment of hypoglycaemia in patients with insulinoma. Clin Endocrinol (Oxf) 1986;25:555-60.
8. Kraenzlin ME, Ch'ng JL, Wood SM, et al. Long-term treatment of a VIPoma with somatostatin analogue resulting in remission of symptoms and possible shrinkage of metastases. Gastroenterology 1985;88:185-7.
9. Kvols LK, Moertel CG, O'Connell MJ, et al. Treatment of the malignant carcinoid syndrome: Evaluation of the long-acting somatostatin analogue. N Engl J Med 1986;315:663-6.
10. Imtiaz KE, Monteith P, Khaleeli A. Complete histological regression of metastatic carcinoid tumour after treatment with octreotide. Clin Endocrinol (Oxf) 2000;53:755-8.